Alternatively Spliced Methionine Synthase in SH-SY5Y Neuroblastoma Cells: Cobalamin and GSH Dependence and Inhibitory Effects of Neurotoxic Metals and Thimerosal.
Mostafa I WalyVerna-Ann Power-CharnitskyNathaniel W HodgsonAlok SharmaTapan AudhyaYiting ZhangRichard C DethPublished in: Oxidative medicine and cellular longevity (2016)
The folate and cobalamin (Cbl-) dependent enzyme methionine synthase (MS) is highly sensitive to oxidation and its activity affects all methylation reactions. Recent studies have revealed alternative splicing of MS mRNA in human brain and patient-derived fibroblasts. Here we show that MS mRNA in SH-SY5Y human neuroblastoma cells is alternatively spliced, resulting in three primary protein species, thus providing a useful model to examine cofactor dependence of these variant enzymes. MS activity was dependent upon methylcobalamin (MeCbl) or the combination of hydroxocobalamin (OHCbl) and S-adenosylmethionine (SAM). OHCbl-based activity was eliminated by depletion of the antioxidant glutathione (GSH) but could be rescued by provision of either glutathionylcobalamin (GSCbl) or MeCbl. Pretreatment of cells with lead, arsenic, aluminum, mercury, or the ethylmercury-containing preservative thimerosal lowered GSH levels and inhibited MS activity in association with decreased uptake of cysteine, which is rate-limiting for GSH synthesis. Thimerosal treatment decreased cellular levels of GSCbl and MeCbl. These findings indicate that the alternatively spliced form of MS expressed in SH-SY5Y human neuronal cells is sensitive to inhibition by thimerosal and neurotoxic metals, and lower GSH levels contribute to their inhibitory action.
Keyphrases
- induced apoptosis
- mass spectrometry
- multiple sclerosis
- ms ms
- cell cycle arrest
- fluorescent probe
- endothelial cells
- oxidative stress
- endoplasmic reticulum stress
- cell death
- dna methylation
- gene expression
- signaling pathway
- binding protein
- cell proliferation
- living cells
- liquid chromatography
- anti inflammatory
- heavy metals
- human health
- single molecule
- combination therapy